NASDAQ · Biotechnology

Vericel Corporation (VCEL) Stock

$40.10 +0.12% NASDAQ: VCEL Healthcare

Valuation

MetricValue
Price$40.10
Market Cap$2.05B
P/E Ratio83.65
P/B Ratio5.53
P/S Ratio6.71
EPS (TTM)$0.32
52-Week High$49.32
52-Week Low$28.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE6.91%
ROA4.82%
ROCE4.05%
Gross Margin3.99%
Operating Margin3.99%
Net Margin7.91%
Debt/Equity0.25
Current Ratio5.04

Annual Financials (USD)

Metric20212022202320242025
Revenue$156.0M$164.0M$198.0M$237.0M$276.0M
Operating Profit$-8.0M$-17.0M$-6.0M$5.0M$11.0M
Net Profit$-7.0M$-17.0M$-3.0M$10.0M$17.0M
EPS$-0.16$-0.35$-0.07$0.20$0.32
Op Margin-5.0%-10.4%-3.3%1.9%4.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$244.0M$273.0M$354.0M$433.0M$488.0M
Total Liabilities$73.0M$81.0M$128.0M$141.0M$133.0M
Cash$68.0M$51.0M$69.0M$75.0M$100.0M
Borrowings$50.0M$48.0M$88.0M$99.0M$98.0M

Latest News

VCEL: What does Argus have to say about VCEL? Argus Research · Jul 22, 2026 Truist Securities Adjusts Price Target on Vericel to $54 From $42, Maintains Buy Rating MT Newswires · Jul 16, 2026 Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026 GlobeNewswire · Jul 16, 2026 Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests Motley Fool · Jun 27, 2026 Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026 GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$29.0M$18.0M$35.0M$58.0M$52.0M
Investing Cash Flow$-11.0M$-44.0M$-31.0M$-143.0M$-71.0M
Financing Cash Flow$-2.0M$-3.0M$-2.0M$-5.0M$-7.0M
Net Cash Flow$35.0M$-17.0M$36.0M$-2.0M$15.0M
Free Cash Flow$21.0M$10.0M$8.0M$-6.0M$25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.34
EV / EBITDA52.61
FCF Yield2.41%
Quick Ratio4.69
Interest Coverage28.49
Return 1Y17.32%
Return 3Y15.08%
Return 5Y-16.30%

Ownership

Insiders Held1.19%
Institutions Held113.74%
Institutions Float Held115.11%
Institutional HolderSharesReport Date
Blackrock Inc.7,765,3442026-03-31
State Street Corporation3,152,1302026-03-31
Congress Asset Management Co2,916,2952026-06-30
Soleus Capital Management, L.P.2,549,0792026-03-31
Conestoga Capital Advisors, LLC2,463,3122026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Vericel Corporation

Vericel Corporation (VCEL) stock trades at $40.10 with a market capitalization of $2.05B. The stock is valued at a price-to-earnings (P/E) ratio of 83.65, price-to-book of 5.53, price-to-sales of 6.71. Over the past 52 weeks the stock has ranged between $28.95 and $49.32, and currently trades 18.7% below its 52-week high.

On profitability, Vericel Corporation generates a return on equity (ROE) of 6.91%, return on capital employed of 4.05%, an operating margin of 3.99%, a net profit margin of 7.91%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides